Business Context and Reporting Period
Company: Arrive AI Inc. (ARAI)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Quarter and six months ended June 30, 2025
Business Overview: Arrive AI is a developmental technology company focused on the Autonomous Last Mile (ALM) market. It designs and implements smart mailboxes ("Arrive Points") for drone, robotic, and human package delivery. The company went public via a direct listing on May 15, 2025, on the Nasdaq Stock Market.
Key Financial Metrics
| Metric | Three Months Ended June 30, 2025 |
Six Months Ended June 30, 2025 |
Six Months Ended June 30, 2024 |
|---|---|---|---|
| Revenue | $90,725 | $90,725 | $0 |
| Net Loss | $(4,689,964) | $(6,668,129) | $(2,375,855) |
| Net Loss Per Share (Basic/Diluted) | $(0.15) | $(0.22) | $(0.08) |
| Cash and Cash Equivalents | $607,496 (Balance Sheet) | $607,496 (Balance Sheet) | $168,815 (Balance Sheet) |
| Operating Cash Flow | N/A | $(3,799,494) | $(1,353,985) |
| Financing Cash Flow | N/A | $4,325,499 | $1,197,328 |
| Total Assets | $8,480,767 | $8,480,767 | $987,788 |
| Total Liabilities | $5,007,868 | $5,007,868 | $1,970,963 |
| Stockholders' Equity | $3,472,899 | $3,472,899 | $(1,046,773) |
Debt Profile: As of June 30, 2025, the company holds a convertible note payable of $4,202,000 (net of discount) to Streeterville Capital LLC, maturing in August 2025. Long-term notes payable total $6,068.
Material Changes vs. Prior Period
- Revenue Generation: The company recorded its first revenue of $90,725 in the current period, compared to $0 in the prior year. Revenue sources include consulting ($89,000), installation ($1,500), and subscriptions ($225).
- Expense Surge: General and Administrative (G&A) expenses increased by 434% ($3.48M) for the quarter and 285% ($4.58M) for the six months. This was driven primarily by one-time success bonuses ($1.87M) related to the public listing and increased stock-based compensation ($1.5M for the quarter).
- Financing Activity: The company raised significant capital in the first half of 2025, including $4.01M from a convertible note and $444k from stock sales, reversing the negative equity position from a deficit of $(983k) at year-end 2024 to positive equity of $3.47M.
- Interest Expense: Interest expense spiked to $194k for the quarter (from $1k prior year) due to the amortization of the original issue discount on the Streeterville convertible note.
Outlook, Risks, and Unusual Items
- Going Concern: Management states that the accumulated deficit of $22.6M and net loss raise substantial doubt about the company's ability to continue as a going concern for twelve months without additional financing.
- Recent Financing: Subsequent to the reporting period (August 11, 2025), the company entered into "Pre-Paid Purchase No. 2" with Streeterville Capital, raising an additional $4.0M in proceeds.
- Strategic Partnerships: The company announced deployments with Hancock Health (biospecimen delivery), Go2 Delivery (specialty pharmacy), and Skye Air Mobility (India drone delivery network).
- Legal Proceedings: An ongoing employment dispute with a former CFO (Byfield Management, Inc.) alleges damages of approximately $29M. Management asserts the claims lack merit due to termination for cause and lack of written contract.
- Tax Legislation: Subsequent to period end, the "Taxpayer Fairness and Growth Act of 2025" was enacted, reducing the corporate tax rate to 19% effective 2026. The company is evaluating the impact on deferred tax assets.
Investor Verification Checklist
- Cash Runway: Verify the sufficiency of the $607k cash balance plus the $4M subsequent financing against the high burn rate (approx. $6.7M net loss for six months).
- Revenue Recurrence: Assess the sustainability of the $90k revenue, noting that $89k was from one-time consulting services rather than recurring subscriptions.
- Debt Maturity: Confirm the repayment or conversion status of the $4.33M Streeterville convertible note maturing in August 2025.
- Legal Exposure: Monitor the status of the Byfield Management litigation and potential settlement costs.
- Stock-Based Compensation: Review the impact of the $2.85M stock-based compensation expense on future dilution and cash flow.